A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development
Authors:
- 25 May 2017
- journal article
- review article
- Published by Wiley in American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Vol. 175 (2) , 304-314
Abstract
Differences of Sex Development (DSD) includes a wide spectrum of etiologies and phenotypes. A subset of individuals with DSDs are predisposed to gonadal germ cell tumor (GCT). In this setting, GCT risk varies widely, depending on the DSD molecular etiology and penetrance. Prognostication based on molecular diagnosis remains challenging, as natural history data specific to recently identified molecular causes of DSD is lacking. In this review, we provide a framework for the clinical geneticist to consider GCT tumor risk in the patient with DSD. We discuss germ cell development and etiology of GCT growth, along with parameters to consider when recommending prophylactic gonadectomy including fertility, hormonal output, and malignant GTC treatment outcomes. Shortly after the 2006 reorganization of DSD nomenclature, literature reviews of natural history publications stratified GCT risk by a chromosomal, pathological, and hormonal taxonomy. Our 2017 literature review reveals a larger body of publications. However, the broad DSD GCT risk stratification within the 2006 taxonomy remains stable. We discuss precise GCT risk assessment for specific diagnoses, including androgen insensitivity, Smith–Lemli–Opitz, and 46,XY with MAP3K1 mutations and gonadal dysgenesis, as examples. We also examine the GCT risk in non‐DSD syndromes, in addition to the cancer risks in DSD patients with dimorphic gonads and genitalia. This review is intended to provide a nuanced assessment of relative germ cell tumor risk in the DSD patient, including modern precise molecular diagnosis, for use by the clinical geneticist.Keywords
Funding Information
- National Cancer Institute (CA114478, CA164947)
- National Institute of General Medical Sciences (T32GM008638)
This publication has 77 references indexed in Scilit:
- Prdm14 promotes germline fate and naive pluripotency by repressing FGF signalling and DNA methylationEMBO Reports, 2013
- Mutation analysis of mitogen activated protein kinase 1 gene in Indian cases of 46,XY disorder of sex developmentIndian Journal of Human Genetics, 2013
- Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2012
- Timing of gonadectomy in adult women with complete androgen insensitivity syndrome (CAIS): patient preferences and clinical evidenceClinical Endocrinology, 2012
- Mutations in MAP3K1 Cause 46,XY Disorders of Sex Development and Implicate a Common Signal Transduction Pathway in Human Testis DeterminationThe American Journal of Human Genetics, 2010
- Testicular Cancer Survivorship: Research Strategies and RecommendationsJNCI: Journal of the National Cancer Institute, 2010
- Androgen Receptor Mutations Associated with Androgen Insensitivity Syndrome: A High Content Analysis Approach Leading to Personalized MedicinePLOS ONE, 2009
- SERKAL Syndrome: An Autosomal-Recessive Disorder Caused by a Loss-of-Function Mutation in WNT4The American Journal of Human Genetics, 2008
- R-spondin1 is essential in sex determination, skin differentiation and malignancyNature Genetics, 2006
- Consensus statement on management of intersex disordersArchives of Disease in Childhood, 2005